Ascendant New York Med Sup Withdrawal Inpatient
-
Services:
- Transportation assistance
- Mental health services
- Suicide prevention services
- Domestic violence services, including family or partner
- Case management service
- Private health insurance
- Cash or self-payment
- Residential/24-hour residential
- Short-term residential
- Residential detoxification
- This facility administers/prescribes medication for alcohol use disorder
- Substance use treatment
- Detoxification
- Vaping not permitted
- HIV testing
- Testing for Hepatitis B (HBV)
- TB screening
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- STD testing
- Breathalyzer or blood alcohol testing
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Female
- Male
- Smoking not permitted
- Screening for mental disorders
- Screening for substance use
- Screening for tobacco use
- Comprehensive substance use assessment
- Comprehensive mental health assessment
- Complete medical history/physical exam
- Self-help groups
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Opioids detoxification
- Private for-profit organization
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- Marital/couples counseling
- Health education services other than HIV/AIDS or hepatitis
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Individual counseling
- Family counseling
- Medications for HIV treatment
- Naltrexone (oral)
- Clonidine
- Medication for mental disorders
- Medications for Hepatitis C treatment
- Acamprosate (Campral®)
- Medications for pre-exposure to prophylaxis
- Disulfiram
- Buprenorphine with naloxone
- Nicotine replacement
- Buprenorphine without naloxone
- Buprenorphine (extended-release, injectable)
- Naltrexone (extended-release, injectable)
- Non-nicotine smoking/tobacco cessation
- In-network prescribing entity
- Other contracted prescribing entity
- No formal relationship with prescribing entity
- Cognitive behavioral therapy
- Motivational interviewing
- Trauma-related counseling
- Substance use disorder counseling
- Relapse prevention
- Telemedicine/telehealth therapy
- Anger management
- 12-step facilitation
- The Joint Commission
- State Substance use treatment agency
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
- Aftercare/continuing care
- Lofexidine or Clonidine detoxification
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine detoxification
- Prescribes naltrexone
- Buprenorphine maintenance
- Adults
- Young Adults
Ancillary Services
Payment/Insurance/Funding Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Alcohol Use Disorder Treatment
Type of Care
Facility Vaping Policy
Testing
Opioid Medications used in Treatment
Gender Accepted
Facility Smoking Policy
Assessment/Pre-treatment
Recovery Support Services
Detoxification (medical withdrawal) Services
Facility Operation (e.g., Private, Public)
Education and Counseling Services
Pharmacotherapies
External Source of Medications Used for Alcohol Use Disorder Treatment
Treatment Approaches
License/Certification/Accreditation
Transitional Services
Type of Opioid Treatment
Age Groups Accepted